If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Download FREE Excerpt
2 Info Graphics
21 Data Graphics
8 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Excellence in product launch evaluation across multiple product launches sets protocols around the launch evaluation process, key performance measures and recalibration of targets post-launch. This research captures quantitative and qualitative data, yielding key findings and insights, around the current and future landscape of product launch evaluation at pharmaceutical and biotech companies.
Best Practices, LLC used both field surveys and interviews to complete this study. In all, 19 sales and marketing leaders contributed data. In-depth interviews were conducted with leaders from six of the participating companies.
NOTE: The data in this research are segmented into two groups: Full Benchmark Class and Large Pharma Segment.
Assessing the success of product launches is a complex yet critical activity to improve both product and process performance. This benchmark study seeks to identify the full range of launch performance measures used to evaluate launch success and to develop benchmarks with which to inform and shape biopharma launch evaluations.
From interviews with executives at six companies, extensive survey data and insights drawn from 19 surveyed companies, this report provides executives, directors, and managers at pharmaceutical companies with actionable insights that will improve post-launch evaluation and stregthen future product launches.
Topics covered in this study include: